Liu et al. [46] have reviewed several studies that have reported that the ATAD2 can regulate different downstream molecules and is overexpressed in various cancer types, including BC, gastric cancer, pancreatic cancer, colorectal cancer, ovarian cancer, uterine corpus endometrial carcinoma, cervical cancer, prostate cancer, renal cancer, and lung cancer. This evidence concerns the gene ATAD2 and lung carcinoma.